Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Geurts-Moespot

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The International Journal of Biological Markers|April 14, 2000
EORTC external quality assurance program for ER and PgR measurements: trial 1998/1999. European Organisation for Research and Treatment of CancerC G Sweep, J Geurts-Moespot
International Journal of Oncology|June 15, 2000
Twenty years of experience with the steroid receptor external quality assessment program - the paradigm for tumour biomarker EQA studies. On behalf of the EROTC Receptor and Biomarker Study GroupJ Geurts-Moespot, R Leake, T J Benraad, et al.
The Journal of Endocrinology|February 1, 1979
Assay of progesterone receptor binding sites with 17,21-dimethyl-19-norpregna-4,9-diene-3,20-dione and 16alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione as the radioactive ligands [proceedings]A J Koenders, J Geurts-Moespot, L V Beex, et al.
Journal of Steroid Biochemistry|October 1, 1978
Estradiol and progesterone receptor activities in stored lyophilised target tissueA J Koenders, J Geurts-Moespot, K H Kho, et al.
Clinical Chemistry|September 23, 2003
Screening for interference in immunoassaysPaul N Span, Nicolai Grebenchtchikov, J Geurts-Moespot, et al.
European Journal of Cancer|January 1, 1980
Steroid hormone receptors in mammary carcinoma: the effect of tamoxifenA J Koenders, L V Beex, J Geurts-Moespot, et al.
The International Journal of Biological Markers|July 7, 2000
EORTC Receptor and Biomarker Study Group Report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extractsP N Span, N Grebenchtchikov, J Geurts-Moespot, et al.
Vox Sanguinis|April 10, 2015
Donation intensity and metabolic syndrome in active whole-blood donorsK Peffer, A L M Verbeek, D W Swinkels, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 22, 2018
HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patientsKarin Abbink, Petra Lm Zusterzeel, Anneke J Geurts-Moespot, et al.
The Lancet. Haematology|October 17, 2017
Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trialsNicole U Stoffel, Colin I Cercamondi, Gary Brittenham, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The International Journal of Biological Markers|April 14, 2000
EORTC external quality assurance program for ER and PgR measurements: trial 1998/1999. European Organisation for Research and Treatment of CancerC G Sweep, J Geurts-Moespot
International Journal of Oncology|June 15, 2000
Twenty years of experience with the steroid receptor external quality assessment program - the paradigm for tumour biomarker EQA studies. On behalf of the EROTC Receptor and Biomarker Study GroupJ Geurts-Moespot, R Leake, T J Benraad, et al.
The Journal of Endocrinology|February 1, 1979
Assay of progesterone receptor binding sites with 17,21-dimethyl-19-norpregna-4,9-diene-3,20-dione and 16alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione as the radioactive ligands [proceedings]A J Koenders, J Geurts-Moespot, L V Beex, et al.
Journal of Steroid Biochemistry|October 1, 1978
Estradiol and progesterone receptor activities in stored lyophilised target tissueA J Koenders, J Geurts-Moespot, K H Kho, et al.
Clinical Chemistry|September 23, 2003
Screening for interference in immunoassaysPaul N Span, Nicolai Grebenchtchikov, J Geurts-Moespot, et al.
European Journal of Cancer|January 1, 1980
Steroid hormone receptors in mammary carcinoma: the effect of tamoxifenA J Koenders, L V Beex, J Geurts-Moespot, et al.
The International Journal of Biological Markers|July 7, 2000
EORTC Receptor and Biomarker Study Group Report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extractsP N Span, N Grebenchtchikov, J Geurts-Moespot, et al.
Vox Sanguinis|April 10, 2015
Donation intensity and metabolic syndrome in active whole-blood donorsK Peffer, A L M Verbeek, D W Swinkels, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 22, 2018
HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patientsKarin Abbink, Petra Lm Zusterzeel, Anneke J Geurts-Moespot, et al.
The Lancet. Haematology|October 17, 2017
Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trialsNicole U Stoffel, Colin I Cercamondi, Gary Brittenham, et al.
Pageof 4